Wegovy 7.2 mg: What You Should Know About the Higher Dose
A new, stronger version of Wegovy — the 7.2 mg semaglutide injection — is now available in the UK. This dose was authorised by the UK medicines regulator (MHRA) in January 2026 following positive results from recent clinical research. It’s designed for people who aren’t getting enough weight loss from the standard 2.4 mg dose.
What Is Wegovy 7.2 mg?
Wegovy 7.2 mg is a once-weekly under-the-skin injection containing the same active ingredient (semaglutide) found in the existing Wegovy range. It represents the highest strength currently offered in the UK. Previously, Wegovy doses only went up to 2.4 mg, but the new 7.2 mg formulation gives a higher amount of the medication in a single week.
How Well Does the Higher Dose Work?
Clinical trials have shown that people using the 7.2 mg dose lose more weight on average than those using lower doses:
- 7.2 mg participants lost a significant portion of their starting weight across the study period.
- This resulted in greater average weight loss than the standard 2.4 mg dose and much more than placebo.
Healthcare professionals recommend tailoring the dose to each person’s response — the goal is maximum benefit while keeping side effects manageable.
Side Effects and What to Expect
The side-effect profile for the 7.2 mg dose appears similar to other Wegovy doses, mainly involving gastrointestinal symptoms such as nausea, constipation or diarrhoea. Some people in trials experienced unusual sensations (like tingling or numbness), but these were generally manageable and usually went away after stopping treatment.
Who Might Be Suitable for the Higher Dose?
The 7.2 mg version is generally aimed at people who:
- Have already worked up to the 2.4 mg dose
- Are not seeing enough weight loss or appetite suppression at that level
Your healthcare provider will review your progress and decide whether moving to the higher dose is appropriate for your weight-loss journey.
Wegovy is licensed in the UK for adults with obesity (BMI 30 +) or those overweight (BMI 27 +) with a related health condition like hypertension or type 2 diabetes.
Availability in the UK
The new 7.2 mg dose is currently available through private prescribers and providers. It is expected that NHS access will come later.
Cost Expectations
Prices vary by provider. The 7.2 mg dose is currently offered at a competitive private rate.
Can I Switch to the 7.2 mg Dose?
Yes — if you’re already taking Wegovy and have reached your current maximum dose, a clinician can assess whether switching to the higher strength is suitable for you. This involves checking how well you’re tolerating the medication and how much weight loss progress you’ve made so far.